People: Bristol-Myers Squibb Co (BMY.N)

BMY.N on New York Stock Exchange

62.07USD
23 Jan 2015
Change (% chg)

$-0.02 (-0.03%)
Prev Close
$62.09
Open
$62.15
Day's High
$62.48
Day's Low
$61.94
Volume
1,157,463
Avg. Vol
1,902,390
52-wk High
$64.44
52-wk Low
$46.32

Search Stocks

Sato, Vicki 

Brief Biography

Dr. Vicki L. Sato Ph.D., is Independent Director of Bristol-Myers Squibb Co. She has been a professor of management practice at the Harvard Business School and professor of the practice of molecular and cell biology at Harvard University since July 2005. In 2005, Dr. Sato retired as President of Vertex Pharmaceuticals Incorporated, a global biotechnology company, where she was responsible for research and development, business and corporate development, commercial operations, legal, and finance. Dr. Sato also served as Chief Scientific Officer, Senior Vice President of Research and Development, and Chair of the Scientific Advisory Board at Vertex before being named President in 2000.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Lamberto Andreotti

20,847,700

James Cornelius

10,859,000

Giovanni Caforio

3,301,850

Charles Bancroft

7,878,020

Louis Schmukler

--

Francis Cuss

3,719,040
As Of 30 Dec 2013
Search Stocks